Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7456 p694
16 June 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Quality of supply could be assessed nationally

Howard Stokoe

Howard Stokoe: contract decisions can be made on the basis of evidence

Local indicators of supplier performance could be brought together to provide information on the reliability of suppliers across the UK.

Outlining the NHS Purchasing and Supply Agency’s work on assessing supplier performance at the summer symposium of the Procurement and Distribution Interest Group (PDIG) of the Guild of Healthcare Pharmacists in Coventry last week, Howard Stokoe, lead category manager for general pharmaceuticals (professional and network) at the NHS PASA, described how the programme would be pushed forward.

Key performance indicators have been developed which can be used to assess which suppliers are delivering lines correctly, on time and in full, and supplying deliveries which do not cause problems for staff. To date, these have been used at a local level, but Mr Stokoe believes that one of the next steps for the NHS PASA should be to look at how to aggregate these indicators to provide information on performance across the UK.

He also described the NHS PASA’s work on its supply chain excellence programme. Reports on individual suppliers’ performances are gathered via regular e-mails and collated, allowing a relative score for each supplier to be developed, based on the average proportion of products with issues delivered by each supplier.

Suppliers can then be ranked according to their relative score, allowing objective measurement of supplier performance. In this way decisions on which companies are awarded contracts can be based on evidence of their past performance.

A report of PDIG’s summer symposium will appear in the next issue of Hospital Pharmacist.

Back to Top


©The Pharmaceutical Journal